An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma

Summary

The purpose of this study is to learn about the safety and the risks of using talimogene laherparepvec in patients who already received treatment with talimogene laherparepvec in study 005/05 (NCT00769704), and to see if extended treatment with talimogene laherparepvec can destroy melanoma tumors.

Timeline

Start

2010-10

Primary completion

2014-09

Completion

2014-09

Drugs

Indications